Use of Ivermectin and Chlorine Dioxide for COVID-19 Treatment and Prophylaxis in Peru: A Narrative Review (2022)

Peer-Reviewed Study · Farfán-Castillo ALM, Moreno-Núñez RS, Zárate-Yuyes FM, Fernández-Rodríguez LJ, Bardales-Zuta VH · 2022

Farfán-Castillo ALM et al., 2022: Narrative review of Peru's use of ivermectin and chlorine dioxide for COVID-19, stating that ivermectin entered the country's approved therapeutic scheme on in-vitro data without demonstrated human efficacy.

ivermectin was part of an approved therapeutic scheme based on in vitro data, although its efficacy in humans was not demonstrated

Farfán-Castillo ALM et al., 2022: Narrative review of Peru's use of ivermectin and chlorine dioxide for COVID-19, stating that ivermectin entered the country's approved therapeutic scheme on in-vitro data without demonstrated human efficacy. Narrative review, no study population; Peru. Authors declare no competing interests. Bearing CONTRADICTS C3's supportive framing while confirming the Peruvian programme existed. Its companion in this run is IVE-29. Both are recorded at full strength per the run's instruction to keep contrary findings. Study type: review.